These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30098970)

  • 1. INTERMACS Profiles and Outcomes Among Non-Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction.
    Samman-Tahhan A; Hedley JS; McCue AA; Bjork JB; Georgiopoulou VV; Morris AA; Butler J; Kalogeropoulos AP
    JACC Heart Fail; 2018 Sep; 6(9):743-753. PubMed ID: 30098970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry.
    Kittleson MM; Shah P; Lala A; McLean RC; Pamboukian S; Horstmanshof DA; Thibodeau J; Shah K; Teuteberg J; Gilotra NA; Taddei-Peters WC; Cascino TM; Richards B; Khalatbari S; Jeffries N; Stevenson LW; Mann D; Aaronson KD; Stewart GC;
    J Heart Lung Transplant; 2020 Jan; 39(1):16-26. PubMed ID: 31522912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitions of Stage D heart failure and outcomes among outpatients with heart failure and reduced ejection fraction.
    Hedley JS; Samman-Tahhan A; McCue AA; Bjork JB; Butler J; Georgiopoulou VV; Morris AA; Kalogeropoulos AP
    Int J Cardiol; 2018 Dec; 272():250-254. PubMed ID: 30122504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression to Stage D Heart Failure Among Outpatients With Stage C Heart Failure and Reduced Ejection Fraction.
    Kalogeropoulos AP; Samman-Tahhan A; Hedley JS; McCue AA; Bjork JB; Markham DW; Bhatt KN; Georgiopoulou VV; Smith AL; Butler J
    JACC Heart Fail; 2017 Jul; 5(7):528-537. PubMed ID: 28624484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of INTERMACS Profile on Clinical Outcomes for Patients Supported With the Total Artificial Heart.
    Shah KB; Thanavaro KL; Tang DG; Quader MA; Mankad AK; Tchoukina I; Thacker LR; Smallfield MC; Katlaps G; Hess ML; Cooke RH; Kasirajan V
    J Card Fail; 2016 Nov; 22(11):913-920. PubMed ID: 27131435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An early relook identifies high-risk trajectories in ambulatory advanced heart failure.
    Kittleson MM; Ambardekar AV; Stevenson LW; Gilotra NA; Shah P; Ewald GA; Thibodeau JT; Stehlik J; Palardy M; Estep JD; Cascino TM; Baldwin JT; Jeffries N; Khalatbari S; Yosef M; Peters WT; Richards B; Mann DL; Aaronson KD; Stewart GC;
    J Heart Lung Transplant; 2022 Jan; 41(1):104-112. PubMed ID: 34629234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
    Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis.
    Adamo L; Tang Y; Nassif ME; Novak E; Jones PG; LaRue S; Spertus JA; Mann DL
    JACC Heart Fail; 2016 Dec; 4(12):950-958. PubMed ID: 27614939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry.
    Barge-Caballero E; Segovia-Cubero J; Almenar-Bonet L; Gonzalez-Vilchez F; Villa-Arranz A; Delgado-Jimenez J; Lage-Galle E; Perez-Villa F; Lambert-Rodríguez JL; Manito-Lorite N; Arizon-Del Prado JM; Brossa-Loidi V; Pascual-Figal D; Fuente-Galan Lde L; Sanz-Julve M; Muñiz-Garcia J; Crespo-Leiro M
    Circ Heart Fail; 2013 Jul; 6(4):763-72. PubMed ID: 23674362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.